Support that is Accelerating Neurofibromatosis type 1 (NF1) Research
With nearly $60 million awarded to more than 80 investigators around the world in the past decade, NTAP is changing the field. NTAP grants come with more than money: Successful applicants gain a network of top advisors including NTAP staff and our many external partners. You may be invited to join a consortium and/or attend virtual and in-person meetings with others working in the same research area, who may enrich or even partner on your project.
Research Funds Committed through 2023
Focusing on therapeutics: Scientific initiatives through 2023
Focusing on therapeutics: Across the continuum of discovery to clinical science
These funds have supported a range of products focused on cutaneous and plexiform neurofibromas, growing the field of NF1 investigators and accelerating NF1 tumor-associated research through critical research tools. Learn more about NTAP-funded initiatives here.